The Joint (JYNT)
(Delayed Data from NSDQ)
$11.46 USD
+0.30 (2.69%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $11.46 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
C Value D Growth B Momentum C VGM
The Joint Corp. (JYNT) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$15.50 | $20.00 | $10.50 | 38.89% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for The Joint Corp. comes to $15.50. The forecasts range from a low of $10.50 to a high of $20.00. The average price target represents an increase of 38.89% from the last closing price of $11.16.
Analyst Price Targets (3 )
Broker Rating
The Joint Corp. currently has an average brokerage recommendation (ABR) of 1.80 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.80 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, three are Strong Buy, representing 60% of all recommendations. A month ago, Strong Buy represented 60%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.80 | 1.80 | 1.80 | 1.80 | 1.80 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/14/2024 | Maxim Group | Anthony V Vendetti | Hold | Hold |
5/6/2024 | B. Riley Securities | Jeffrey W Van Sinderen | Strong Buy | Strong Buy |
5/3/2024 | Roth Capital Partners | George Kelly | Strong Buy | Strong Buy |
5/3/2024 | Lake Street Capital Markets | Ryan R Meyers | Not Available | Strong Buy |
5/3/2024 | Craig-Hallum | Jeremy Hamblin | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.80 |
ABR (Last week) | 1.80 |
# of Recs in ABR | 5 |
Average Target Price | $15.50 |
LT Growth Rate | NA |
Industry | Medical - HMOs |
Industry Rank by ABR | 227 of 253 |
Current Quarter EPS Est: | 0.04 |